Ligelizumab (QGE 031) is a high-affinity humanized monoclonal antibody targeting immunoglobulin E (IgE). This antibody is specifically designed for the study of chronic spontaneous urticaria, providing a valuable tool for investigating the pathophysiology and therapeutic interventions of this condition.
Ligelizumab (QGE 031) is a high-affinity humanized monoclonal antibody targeting immunoglobulin E (IgE). This antibody is specifically designed for the study of chronic spontaneous urticaria, providing a valuable tool for investigating the pathophysiology and therapeutic interventions of this condition.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: